GEB-101

N/A

Report date: 2026/05/25 10:08:07

Base Information

Drug NameGEB-101
Drug Alias NameGEB-101
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionTransforming Growth Factor, Beta-Induced modulators
TargetsTransforming Growth Factor, Beta-Induced
Therapy Area/IndicationsCorneal dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesBeijing Yinzheng Gene Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Yinzheng Gene Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCorneal dystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A